Currently predicting for Tue, 28 May 2024

CLVS Predictions History

4 years ago
Omar.Elgusbi.87144 predicted that CLVS for 2020-05-22 is going $9.31 (23.64%)

Rank:

4 years ago
JS predicted that CLVS for 2020-05-20 is going $6.97 (-7.07%)

4 years ago
Omar.Elgusbi.87144 predicted that CLVS for 2020-05-20 is going $9.52 (26.93%)

Rank:

4 years ago
2poJeff predicted that CLVS for 2020-01-21 is going $9.92 (0.71%)

4 years ago
JS predicted that CLVS for 2020-01-21 is going $10.15 (3.05%)

4 years ago
Chuck predicted that CLVS for 2020-01-21 is going $12.50 (26.90%)

Rank:

4 years ago
JS predicted that CLVS for 2019-12-16 is going $12.27 (1.32%)

4 years ago
Martin predicted that CLVS for 2019-12-16 is going

Rank:

4 years ago
Hendrik Jander predicted that CLVS for 2019-12-16 is going $34.00 (164.39%)

Rank:

4 years ago
Jerry Ky predicted that CLVS for 2019-12-16 is going

Rank:
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT